PMC:7408073 / 0-354
Annnotations
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T1 | 68-92 | Body_part | denotes | Renin-Angiotensin System | http://purl.obolibrary.org/obo/UBERON_0018229 |
| T2 | 193-217 | Body_part | denotes | renin-angiotensin system | http://purl.obolibrary.org/obo/UBERON_0018229 |
| T3 | 219-222 | Body_part | denotes | RAS | http://purl.obolibrary.org/obo/UBERON_0018229 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 4 | 20-23 | Gene | denotes | ACE | Gene:59272 |
| 5 | 24-28 | Gene | denotes | ACE2 | Gene:59272 |
| 6 | 68-73 | Gene | denotes | Renin | Gene:5972 |
| 7 | 107-115 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 25 | 256-264 | Species | denotes | patients | Tax:9606 |
| 26 | 277-287 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 31 | 265-273 | Disease | denotes | infected | MESH:D007239 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 107-115 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T2 | 277-285 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T3 | 277-281 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T1 | 74-85 | Chemical | denotes | Angiotensin | http://purl.obolibrary.org/obo/CHEBI_2719 |
| T2 | 199-210 | Chemical | denotes | angiotensin | http://purl.obolibrary.org/obo/CHEBI_48433 |
| T3 | 219-222 | Chemical | denotes | RAS | http://purl.obolibrary.org/obo/CHEBI_63620 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-38 | Sentence | denotes | The Yin and Yang of ACE/ACE2 Pathways: |
| T2 | 39-124 | Sentence | denotes | The Rationale for the Use of Renin-Angiotensin System Inhibitors in COVID-19 Patients |
| T3 | 126-134 | Sentence | denotes | Abstract |
| T4 | 135-342 | Sentence | denotes | The article describes the rationale for inhibition of the renin-angiotensin system (RAS) pathways as specific targets in patients infected by SARS-CoV-2 in order to prevent positive feedback-loop mechanisms. |